Melatonin improves sleep in asthma: A randomized, double-blind, placebo-controlled study

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 9, 2004, Pages 947-951

  Campos, Francineide L ^a   Da Silva Júnior, Francisco P ^a   De Bruin, Veralice M S ^a   De Bruin, Pedro F C ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Asthma; Excessive somnolence; Melatonin; Sleep

Indexed keywords

MELATONIN;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; EPIGASTRIC PAIN; EPWORTH SLEEPINESS SCALE; FEMALE; HEADACHE; HUMAN; INFLAMMATION; LUNG FUNCTION; OUTCOMES RESEARCH; PEAK EXPIRATORY FLOW; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SLEEP; SLEEP DISORDER; SMOOTH MUSCLE TONE; SOMNOLENCE; SPIROMETRY;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ASTHMA; DISORDERS OF EXCESSIVE SOMNOLENCE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELATONIN; MIDDLE AGED; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 7044269602     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200404-488OC     Document Type: Article

References (58)

1. Janson C, De Backer W, Gislason T, Plaschke P, Björnsson E, Hetta J, Kristbjarnarson H, Vermeire P, Boman G. Increased prevalence of sleep disturbances and daytimes sleepiness in subjects with bronchial asthma: a population study of young adults in three European countries. Eur Respir J 1996;9:2132-2138.
2. Fitzpatrick MF, Engleman H, Whyte KF, Deary IJ, Shapiro CM, Douglas NJ. Morbidity in nocturnal asthma: sleep quality and daytime cognitive performance. Thorax 1991;46:569-573.
3. Sadeh A, Horowitz I, Wolach-Benodis L, Wolach B. Sleep and pulmonary function in children with well-controlled, stable asthma. Sleep 1998;21:379-384.
4. Roehrs T, Merlotti L, Halpin D, Rosenthal L, Roth T. Effects of theophylline on nocturnal sleep and daytime sleepiness/alertness. Chest 1995;108:382-387.
5. Vir R, Bhagat R, Shah A. Sleep disturbances in clinically stable young asthmatic adults. Ann Allergy Asthma Immunol 1997;79:251-255.
6. Goldney RD, Ruffin R, Fisher LJ, Wilson DH. Asthma symptoms associated with depression and lower quality of life: a population survey. Med J Aust 2003;178:437-441.
7. Arendt J. Melatonin, circadian rhythms, and sleep. N Engl J Med 2000;343:1114-1116.
8. Stone BM, Turner C, Mills SL, Nicholson AN. Hypnotic activity of melatonin. Sleep 2000;23:663-669.
9. Bruderman I, Rahamimoff R. Alterations in tracheobronchial smooth muscle activity following melatonin. J Appl Physiol 1967;23:938-943.
10. Doolen S, Krause DN, Dubocovich ML, Duckles SP. Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol 1998;345:67-69.
11. Reiter RJ, Calvo JR, Karbownik M, Qi W, Tan DX. Melatonin and its relation to the immune system and inflammation. Ann NY Acad Sci 2000;917:376-386.
12. Conti A, Maestroni GJ. The clinical neuroimmunotherapeutic role of melatonin in oncology. J Pineal Res 1995;19:103-110.
13. Zhang Z, Inserra PF, Liang B, Ardestani SK, Elliott KK, Molitor M, Watson RR. Melatonin, immune modulation and aging. Autoimmunity 1997;26:43-53.
14. Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow-Walden L, Chuang J, Ortiz GG, Acuna-Castroviejo D. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995;18:1-11.
15. Cuzzocrea S, Reiter RJ. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur J Pharmacol 2001;426:1-10.
16. Pawlikowski M, Kolomecka M, Wojtczak A, Karasek M. Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, and somatomedin C in elderly women. Neuroendocrinol Lett 2002;23:17-19.
17. Pires MLN, Benedito-Silva AA, Pinto L, Souza L, Vismari L, Calil HM. Acute effects of low doses of melatonin on the sleep of young healthy subjects. J Pineal Res 2001;31:326-332.
18. Shilo L, Dagan Y, Smorjik Y, Weinberg U, Dolev S, Komptel B, Shenkman L. Effect of melatonin on sleep quality of COPD intensive care patients: a pilot study. Chronobiol Int 2000;17:71-76.
19. Seabra MLV, Bignotto M, Pinto LR Jr, Tufik S. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res 2000;29:193-200.
20. National Institutes of Health/National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program Expert Panel. Clinical Practice Guidelines. Expert Panel Report: guidelines for the diagnosis and management of asthma - update on selected topics 2002. Bethesda, MD: National Institutes of Health/National Heart, Lung, and Blood Institute; 2003. NIH publication No. 02-5074.
21. Fourtillan JB, Brisson AM, Gobin P, Ingrand I, Decourt JP, Girault J. Bioavailability of melatonin in humans after day-time administration of D(7) melatonin. Biopharm Drug Dispos 2000;21:15-22.
22. American Thoracic Society. Standardization of spirometry 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
23. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
24. Johns MW. A new method of measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-545.
25. Norusis MJ. SPSS for Windows: Base System User's Guide 1993, release 6.0.
26. Vgontzas AN, Bixler EO, Kales A, Manfredi RL, Tyson K. Validity and clinical utility of sleep laboratory criteria for insomnia. Int J Neurosci 1994;77:11-21.
27. Hughes RJ, Badia P. Sleep-promoting and hypothermic effects of daytime melatonin administration in humans. Sleep 1997;20:124-131.
28. Lavie P. Melatonin: role in gating nocturnal rise in sleep propensity. J Biol Rhythms 1997;12:657-665.
29. Waldhauser F, Saletu B, Trinchard-Lugan I. Sleep laboratory investigations on hypnotic properties of melatonin. Psychopharmacology (Berl) 1990;100:222-226.
30. Zhdanova IV, Wurtman RJ, Lynch HJ, Ives JR, Dollins AB, Morabito C, Matheson JK, Schomer DL. Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 1995;57:552-558.
31. Cajochen C, Krauchi K, Danilenko KV, Wirz-Justice A. Evening administration of melatonin and bright light: interactions on the EEG during sleep and wakefulness. J Sleep Res 1998;7:145-157.
32. James SP, Sack DA, Rosenthal NE, Mendelson WB. Melatonin administration in insomnia. Neuropsychopharmacology 1990;3:19-23.
33. MacFarlane JG, Cleghorn JM, Brown GM, Streiner DL. The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: a preliminary study. Biol Psychiatry 1991;30:371-376.
34. Hughes RJ, Sack RL, Lewy AJ. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement. Sleep 1998;21:52-68.
35. Dawson D, Rogers NL, van den Heuvel CJ, Kennaway DJ, Lushington K. Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs. J Biol Rhythms 1998;13:532-538.
36. Arendt J, Deacon S. Treatment of circadian rhythm disorders-melatonin. Chronobiol Int 1997;14:185-204.
37. Zhdanova IV, Lynch HJ, Wurtman RJ. Melatonin: a sleep-promoting hormone. Sleep 1997;20:899-907.
38. Tenn CC, Niles LP. Central-type benzodiazepine receptors mediate the antidopaminergic effect of clonazepam and melatonin in 6-hydroxydopamine lesioned rats: involvement of a GABAergic mechanism. J Pharmacol Exp Ther 1995;274:84-89.
39. Nave R, Herer P, Haimov I, Shlitner A, Lavie P. Hypnotic and hypothermic effects of melatonin on daytime sleep in humans: lack of antagonism by flumazenil. Neurosci Lett 1996;214:123-126.
40. Rogers NL, Dinges DF, Kennaway DJ, Dawson D. Potential action of melatonin in insomnia. Sleep 2003;26:1058-1059.
41. Sack RL, Hughes RJ, Edgar DM, Lewy AJ. Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms? Sleep 1997;20:908-915.
42. Zhdanova IV, Simmons M, Marcus JN, Busza AC, Leclair OU, Taylor JA. Nocturnal increase in plasma cGMP levels in humans. J Biol Rhythms 1999;14:307-313.
43. Zhdanova IV, Raz DJ. Effects of melatonin ingestion on cAMP and cGMP levels in human plasma. J Endocrinol 1999;163:457-462.
44. Hetzel MR, Clark TJH. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 1980;35:732-738.
45. Montplaisir J, Walsh J, Malo JL. Nocturnal asthma features of attacks, sleep and breathing patterns. Am Rev Respir Dis 1982;125:18-22.
46. Rahamimoff R, Bruderman I. Changes in pulmonary mechanics induced by melatonin. Life Sci 1965;4:1383-1389.
47. Rahamimoff R, Bruderman I, Golshani G. Effect of melatonin on 5-hydroxytryptamine induced contraction of isolated cat trachea. Life Sci 1965;4:2281-2287.
48. Weekley LB. Influence of melatonin on bovine pulmonary vascular and bronchial airway smooth muscle tone. Clin Auton Res 1995;5:53-56.
49. De Bruin PFC, Alves NA, De Bruin VMS, Carrasco AEAB, Magalhaes PJC. The in vitro effect of melatonin on human airway smooth muscle [abstract]. Am J Respir Crit Care Med 2001;163:A637.
50. DeMuro RL, Nafziger AN, Blask DE, Menhinick AM, Bertino JS. The absolute bioavailability of oral melatonin. J Clin Pharmacol 2000;40:781-784.
51. Maksoud A, Moore CA, Hirshkowitz M. The effect of melatonin administration on patients with sleep apnea. Sleep Res 1997;26:114.
52. Hong YG, Riegler JL. Is melatonin associated with the development of autoimmune hepatitis? J Clin Gastroenterol 1997;25:376-378.
53. Luboshitzky R, Shen-Orr Z, Nave R, Lavi S, Lavie P. Melatonin administration alters semen quality in healthy men. J Androl 2002;23:572-578.
54. Sulli A, Maestroni GJ, Villaggio B, Hertens E, Craviotto C, Pizzorni C, Briata M, Seriolo B, Cutolo M. Melatonin serum levels in rheumatoid arthritis. Ann NY Acad Sci 2002;966:276-283.
55. Sutherland ER, Ellison MC, Kraft M, Martin RJ. Elevated serum melatonin is associated with the nocturnal worsening of asthma. J Allergy Clin Immunol 2003;112:513-517.
56. Wang YT, Chen SL, Xu SY. Effect of melatonin on the expression of nuclear factor-kappa B and airway inflammation in asthmatic rats. Zhonghua Er Ke Za Zhi 2004;42:94-97.
57. Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory disease. N Engl J Med 1997;336:1066-1071.
58. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993;14:436-441.